UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000016064
Receipt number	R000018669
Scientific Title	Phase 2 study of the treatment discontinuation after the change from 2nd tyrosine kinase inhibitors to Interferon-alpha in chronoic myeloid leukemia patients who maintained molecular remission.
Date of disclosure of the study information	2015/01/05
Last modified on	2017/12/28 09:04:04

---